Prevalence of anxiety and depressive symptoms and impact on self-management among adults with chronic conditions in Chicago, Illinois, USA, during the COVID-19 pandemic: a cross-sectional survey.
Prevalence of anxiety and depressive symptoms and impact on self-management among adults with chronic conditions in Chicago, Illinois, USA, during the COVID-19 pandemic: a cross-sectional survey.
复制标题
DOI：
10.1136/bmjopen-2021-052495
复制
发表时间：
2022-01-07
期刊：
影响因子：
2.9
通讯作者：
Wolf MS
中科院分区：
文献类型：
--
作者：
Lovett RM;Opsasnick L;Russell A;Yoon E;Weiner-Light S;Serper M;Cooper Bailey S;Wolf MS
研究美国COVID-19首次爆发期间精神健康症状的流行情况，以及它们与COVID-19相关情绪困扰、健康自我管理和医疗保健利用的关系。正在进行的芝加哥COVID-19合并症（C3）研究的第3波（2020年5月1日至22日）调查数据的横断面分析。伊利诺斯州芝加哥的七个学术和社区健康中心。565名年龄在23-88岁之间的成年人，患有一种或多种慢性疾病，完成了至少一次既往C3研究波。使用患者报告结局测量信息系统简表测量的临床相关焦虑和抑郁症状。通过单项问题和经验证的措施相结合，测量了自我报告的对COVID-19的情绪和健康相关反应。焦虑和抑郁症状的发生率分别为14%（81/563）和15%（84/563）。焦虑和抑郁症状分别与感染COVID-19的担忧有关（相对危险度（RR）2.32，95% CI 1.52 - 3.53; RR 1.67，95% CI 1.10 - 2.54），压力较大（RR 4.93，95% CI 3.20 - 7.59; RR 3.01，95% CI 1.96 - 4.61）和孤独感（RR 3.82，95% CI 2.21至6.60; RR 5.37，95% CI 3.21至8.98），更大程度地回避医生（RR 1.62，95% CI 1.06 - 2.49; RR 1.54，95% CI 1.00 - 2.36）和难以管理健康（最小二乘均值（LS均值）6.09，95% CI 5.25至6.92 vs 4.23，95% CI 3.70至4.75; LS均值5.85，95% CI 5.04至6.65 vs 4.22，95% CI 3.70至4.75）和药物（LS均值3.71，95% CI 2.98至4.43 vs 2.47，95% CI 2.02至2.92）。识别和解决心理健康问题可能是高风险医疗人群中COVID-19预防和管理的重要考虑因素。
To examine the prevalence of mental health symptoms during the first surge of COVID-19 in the USA, and their associations with COVID-19-related emotional distress, health self-management and healthcare utilisation. Cross-sectional analysis of wave 3 (1–22 May 2020) survey data from the ongoing Chicago COVID-19 Comorbidities (C3) study. Seven academic and community health centres in Chicago, Illinois. 565 adults aged 23–88 with one or more chronic conditions completing at least one prior C3 study wave. Clinically relevant anxiety and depressive symptoms as measured using Patient-Reported Outcomes Measurement Information System short forms. Self-reported emotional and health-related responses to COVID-19 were measured through a combination of single-item questions and validated measures. Rates of anxiety and depressive symptoms were 14% (81/563) and 15% (84/563), respectively. Anxiety and depressive symptoms were then each separately associated with greater worry about contracting COVID-19 (relative risk (RR) 2.32, 95% CI 1.52 to 3.53; RR 1.67, 95% CI 1.10 to 2.54), greater stress (RR 4.93, 95% CI 3.20 to 7.59; RR 3.01, 95% CI 1.96 to 4.61) and loneliness (RR 3.82, 95% CI 2.21 to 6.60; RR 5.37, 95% CI 3.21 to 8.98), greater avoidance of the doctor (RR 1.62, 95% CI 1.06 to 2.49; RR 1.54, 95% CI 1.00 to 2.36) and difficulty managing health (least square means (LS Means) 6.09, 95% CI 5.25 to 6.92 vs 4.23, 95% CI 3.70 to 4.75; LS Means 5.85, 95% CI 5.04 to 6.65 vs 4.22, 95% CI 3.70 to 4.75) and medications (LS Means 3.71, 95% CI 2.98 to 4.43 vs 2.47, 95% CI 2.02 to 2.92) due to the pandemic. Identifying and addressing mental health concerns may be an important factor to consider in COVID-19 prevention and management among high-risk medical populations.
登录
查看更多内容
影响因子：
5.9
作者：
Khubchandani J;Sharma S;Price JH;Wiblishauser MJ;Sharma M;Webb FJ
通讯作者：
Webb FJ
DOI：
10.1177/0272989x17753392
发表时间：
2018-04
期刊：
Medical decision making : an international journal of the Society for Medical Decision Making
影响因子：
--
作者：
Wolf MS;Smith SG;Pandit AU;Condon DM;Curtis LM;Griffith J;O'Conor R;Rush S;Bailey SC;Kaplan G;Haufle V;Martin D
通讯作者：
Martin D
DOI：
10.3399/bjgp20x713021
发表时间：
2020-11
期刊：
The British journal of general practice : the journal of the Royal College of General Practitioners
影响因子：
--
作者：
Wong SYS;Zhang D;Sit RWS;Yip BHK;Chung RY;Wong CKM;Chan DCC;Sun W;Kwok KO;Mercer SW
通讯作者：
Mercer SW
DOI：
10.1093/geronb/gbaa074
发表时间：
2021-02-01
影响因子：
6.2
作者：
de Bruin, Wandi Bruine
通讯作者：
de Bruin, Wandi Bruine
DOI：
10.1037/tra0000924
发表时间：
2020-08-01
影响因子：
6.3
作者：
Fitzpatrick, Kevin M.;Harris, Casey;Drawve, Grant
通讯作者：
Drawve, Grant